echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Shenjian CA (IF=286): Continuous weight loss - reduce the risk of cancer by 32% and reduce the risk of cancer death by 48%!

    Shenjian CA (IF=286): Continuous weight loss - reduce the risk of cancer by 32% and reduce the risk of cancer death by 48%!

    • Last Update: 2023-01-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit

    Although obesity is widely recognized as a cancer risk factor, few studies have shown that losing weight and maintaining that reduction reduces the risk
    of developing certain cancers and possibly dying from certain cancers.
    Although the underlying biological mechanisms are still not fully understood, many believe that obesity can stimulate cancer development and growth by causing increased inflammation, altering the microbiota, causing insulin resistance, and increasing levels of circulating insulin-like growth
    factor, estrogen.

    This article is the original of Translational Medicine Network, please indicate the source for reprinting

    Written by Sophia

    Research background


    To investigate more deeply whether weight loss can reduce cancer risk and mortality, the researchers conducted surgical versus long-term efficacy studies of oncological morbidity and mortality, comparing adult obese patients undergoing bariatric surgery on CCHS with obese patients who had not undergone bariatric surgery for 17 years in an adult control group

    The primary composite endpoint of this retrospective, observational, matched cohort study was the time to onset of one of 13 obesity-related cancers: esophageal adenocarcinoma, renal cell carcinoma, postmenopausal breast cancer, cardia cancer, and breast cancer
    colon, rectum, liver, gallbladder, pancreas, ovaries, uterine body, or thyroid; and multiple myeloma
    The secondary endpoint was cancer-related mortality

    The study included 5053 obese adults
    who underwent Roux-en-Y gastric bypass or sleeve gastrectomy at Cleveland Clinic Hospital between 2004 and 2017.
    Each surgical patient was matched
    to 5 patients who did not undergo bariatric surgery.
    The 25,265 non-surgical control patients were selected by logistic regression models based on 10 potentially self-reported potential confounders, including: race (black, white, or other), body mass index (35-39.
    9, 40-44.
    9, 45-49.
    9, 50–54.
    9, 55–59.
    9, or 60–80 kg/m 2), smoking history (never, before, or present), presence of type 2 diabetes, Elixhauser comorbidity index, Charlson comorbidities index and state of residence (classified as the sum of Florida or Ohio or other U.

    The median age of patients is 46 years
    Most were women (77%) and 73% were white
    The median follow-up was 5.
    8 years in the bariatric surgery group and 6.
    1 years
    in the non-surgical control group.

    Study results


    Studies show that the risk of developing 13 different types of cancer increases with obesity, and these cancers account for 40%
    of all annual cancer diagnoses in the United States.
    Over 10 years, the bariatric surgery group lost 19.
    2% more body weight than the control group, which equates to a weight loss of 54.
    7 pounds
    The researchers also found that 96 patients in the bariatric surgery group and 780 patients in the non-surgical control group developed obesity-related cancers during a follow-up period from 17 to 21 years, resulting in a 10-year cumulative incidence of cancer of 2.
    9% in the bariatric surgery group and 4.
    in the non-surgical control group.

    In addition, 21 patients (0.
    41%) in the bariatric surgery group and 205 patients (0.
    81%) in the control group died from cancer-related causes; These rates correspond to 0.
    6 and 1.
    2 cancer-related deaths
    per 1000 person-years follow-up, respectively.
    That is, bariatric surgery patients had a 32% lower incidence of obesity-related cancer and a 48%
    lower risk of cancer death compared to non-surgical control patients.

    Research significance


    According to the clinic's official report: the more weight you lose, the lower
    your risk of cancer.
    The findings also suggest that weight loss through bariatric surgery can reduce the risk of developing precancerous lesions such as endometrial hyperplasia, breast ductal carcinoma in situ, colorectal polyps, and Barret's esophagus

    However, Dr.
    Lauren R.
    Teras noted that the study did not find that bariatric surgery reduced the risk of
    breast cancer.
    This may be due to the younger age of the participants, who entered the study at an average age of 46 years and had a median follow-up of about 6 years
    The increased risk of breast cancer due to obesity is limited to postmenopausal breast cancer
    Therefore, a study that includes older patients or patients with longer follow-up may show more favorable outcomes, including reduced breast cancer incidence and mortality

    McCullough noted that the criteria for evaluating who is a good candidate for bariatric surgery comes from many sources, including the American Society for Metabolic and Bariatric Surgery and the National Institute of Diabetes, Digestive and Kidney Diseases, and for general guidance on cancer prevention, clinicians can refer to the American Cancer Society's Diet and Physical Activity Cancer Prevention Guidelines




    Note: This article is intended to introduce the progress of medical research and cannot be used as a reference
    for treatment options.
    If you need health guidance, please go to a regular hospital

    Referrals, live broadcasts/events

    November 24-27 09:00-17:30 Shanghai

    The 4th Shanghai International Cancer Congress

    Scan the code to participate

    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.